Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© Paula Rocktaeschel
Immunofluorescent labelling of two non-neuronal, glial cells (so-called astrocytes) generated from human stem cells to examine the impact of neuronal-glial interaction on epileptogenesis.

We maintain a strong focus on basic scientific research that can lead to therapeutic benefit.

For example, current projects include work examining the TSC2 complex of tuberous sclerosis, electrophysiological studies of surgically resected epileptogenic tissue and deregulation of NMDA receptor function in hippocampal sclerosis.

We are part of the Oxford Neurodevelopment Consortium and are keen to engage with partners interested in improved molecular understanding of what drives seizures.

Selected publications